M. Welliver, D. Cheek, J. Osterbrink, and J. Mcdonough, Worldwide experience with sugammadex sodium: implications for the United States, AANA J. avr, vol.83, issue.2, pp.107-122, 2015.

T. Fuchs-buder, C. Meistelman, and J. Schreiber, Is sugammadex economically viable for routine use, Current Opinion in Anaesthesiology, vol.25, issue.2, pp.217-237, 2012.
DOI : 10.1097/ACO.0b013e32834f012d

L. Van-gestel and G. Cammu, Is the effect of sugammadex always rapid in onset?, Acta Anaesthesiol Belg, vol.64, issue.2, pp.41-48, 2013.

M. Abdulatif, H. Mowafi, A. Ghamdi, and M. Sanabary, Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults, British Journal of Anaesthesia, vol.77, issue.6, pp.710-715, 1996.
DOI : 10.1093/bja/77.6.710

T. Fuchs-buder, C. Meistelman, A. F. Grandjean, A. Wuthrich, Y. Donati et al., Antagonism of Low Degrees of Atracurium-induced Neuromuscular Blockade, Anesthesiology, vol.112, issue.1, pp.34-40, 2010.
DOI : 10.1097/ALN.0b013e3181c53863

C. Meistelman and T. Fuchs-buder, Pharmacologie du sugammadex, Annales Fran??aises d'Anesth??sie et de R??animation, vol.28, pp.51-57, 2009.
DOI : 10.1016/S0750-7658(09)72488-8

F. Gijsenbergh, S. Ramael, N. Houwing, and T. Van-iersel, First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide, Anesthesiology, vol.103, issue.4, pp.695-703, 2005.
DOI : 10.1097/00000542-200510000-00007

O. Epemolu, A. Bom, F. Hope, and R. Mason, Reversal of Neuromuscular Blockade and Simultaneous Increase in Plasma Rocuronium Concentration after the Intravenous Infusion of the Novel Reversal Agent Org 25969, Anesthesiology, vol.99, issue.3, pp.632-639, 2003.
DOI : 10.1097/00000542-200309000-00018

N. Rahe-meyer, H. Fennema, S. Schulman, W. Klimscha, M. Przemeck et al., Effect of Reversal of Neuromuscular Blockade with Sugammadex versus Usual Care on Bleeding Risk in a Randomized Study of Surgical Patients, Anesthesiology, vol.121, issue.5, pp.969-77, 2014.
DOI : 10.1097/ALN.0000000000000424

R. Mirakhur, Sugammadex in clinical practice, Anaesthesia, vol.55, issue.Suppl. 34, pp.45-54, 2009.
DOI : 10.1213/00000539-198108000-00004

T. Christie and H. Churchill-davidson, THE ST. THOMAS'S HOSPITAL NERVE STIMULATOR IN THE DIAGNOSIS OF PROLONGED APN??A, The Lancet, vol.271, issue.7024, p.776, 1958.
DOI : 10.1016/S0140-6736(58)91583-6

C. Baillard, G. Gehan, J. Reboul-marty, P. Larmignat, C. Samama et al., Residual curarization in the recovery room after vecuronium, British Journal of Anaesthesia, vol.84, issue.3, pp.394-399, 2000.
DOI : 10.1093/oxfordjournals.bja.a013445

B. Debaene, B. Plaud, M. Dilly, and F. Donati, Residual Paralysis in the PACU after a Single Intubating Dose of Nondepolarizing Muscle Relaxant with an Intermediate Duration of Action, Anesthesiology, vol.98, issue.5, pp.1042-1050, 2003.
DOI : 10.1097/00000542-200305000-00004

A. Kopman, P. Yee, and G. Neuman, Relationship of the Train-of-four Fade Ratio to Clinical Signs and Symptoms of Residual Paralysis in Awake Volunteers, Anesthesiology, vol.86, issue.4, pp.765-71, 1997.
DOI : 10.1097/00000542-199704000-00005

L. Eriksson, E. Sundman, R. Olsson, L. Nilsson, H. Witt et al., Functional Assessment of the Pharynx at Rest and during Swallowing in Partially Paralyzed Humans, Anesthesiology, vol.87, issue.5, pp.1035-1078, 1997.
DOI : 10.1097/00000542-199711000-00005

G. Murphy, J. Szokol, J. Marymont, S. Greenberg, M. Avram et al., Residual Neuromuscular Blockade and Critical Respiratory Events in the Postanesthesia Care Unit, Anesthesia & Analgesia, vol.107, issue.1, pp.130-137, 2008.
DOI : 10.1213/ane.0b013e31816d1268

E. Sundman, H. Witt, R. Olsson, O. Ekberg, R. Kuylenstierna et al., The Incidence and Mechanisms of Pharyngeal and Upper Esophageal Dysfunction in Partially Paralyzed Humans, Anesthesiology, vol.92, issue.4, pp.977-84, 2000.
DOI : 10.1097/00000542-200004000-00014

M. Eikermann, H. Groeben, J. Hüsing, and J. Peters, Accelerometry of Adductor Pollicis Muscle Predicts Recovery of Respiratory Function from Neuromuscular Blockade, Anesthesiology, vol.98, issue.6, pp.1333-1340, 2003.
DOI : 10.1097/00000542-200306000-00006

H. Berg, J. Roed, J. Viby-mogensen, C. Mortensen, J. Engbaek et al., Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium, Acta Anaesthesiologica Scandinavica, vol.8, issue.9, pp.1095-103, 1997.
DOI : 10.1111/j.1399-6576.1997.tb04851.x

R. Miller, How Should Residual Neuromuscular Blockade be Detected?, Anesthesiology, vol.70, issue.3, pp.379-80, 1989.
DOI : 10.1097/00000542-198903000-00001

J. Viby-mogensen, N. Jensen, J. Engbaek, H. Ording, L. Skovgaard et al., Tactile and Visual Evaluation of the Response to Train-of-four Nerve Stimulation, Anesthesiology, vol.63, issue.4, pp.440-443, 1985.
DOI : 10.1097/00000542-198510000-00015

H. Ali, R. Wilson, J. Savarese, and R. Kitz, THE EFFECT OF TUBOCURARINE ON INDIRECTLY ELICITED TRAIN-OF-FOUR MUSCLE RESPONSE AND RESPIRATORY MEASUREMENTS IN HUMANS, British Journal of Anaesthesia, vol.47, issue.5
DOI : 10.1093/bja/47.5.570

C. Baillard, C. Clec-'h, J. Catineau, F. Salhi, G. Gehan et al., Postoperative residual neuromuscular block: a survey of management, British Journal of Anaesthesia, vol.95, issue.5, pp.622-628, 2005.
DOI : 10.1093/bja/aei240

S. Groudine, R. Soto, C. Lien, D. Drover, and K. Roberts, A Randomized, Dose-Finding, Phase II Study of the Selective Relaxant Binding Drug, Sugammadex, Capable of Safely Reversing Profound Rocuronium-Induced Neuromuscular Block, Anesthesia & Analgesia, vol.104, issue.3, pp.555-62, 2007.
DOI : 10.1213/01.ane.0000260135.46070.c3

I. Sorgenfrei, K. Norrild, P. Larsen, J. Stensballe, D. Ostergaard et al., Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex, Anesthesiology, vol.104, issue.4, pp.667-74, 2006.
DOI : 10.1097/00000542-200604000-00009

S. Schaller, H. Fink, K. Ulm, and M. Blobner, Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block, Anesthesiology, vol.113, issue.5, pp.1054-60, 2010.
DOI : 10.1097/ALN.0b013e3181f4182a

H. Sparr, K. Vermeyen, A. Beaufort, H. Rietbergen, J. Proost et al., Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study, Anesthesiology, vol.106, issue.5, pp.935-978, 2007.
DOI : 10.1097/01.anes.0000265152.78943.74

H. De-boer, J. Driessen, M. Marcus, H. Kerkkamp, M. Heeringa et al., Reversal of Rocuronium-induced (1.2 mg/kg) Profound Neuromuscular Block by Sugammadex, Anesthesiology, vol.107, issue.2, pp.239-283, 2007.
DOI : 10.1097/01.anes.0000270722.95764.37

L. Van-gestel and G. Cammu, Is the effect of sugammadex always rapid in onset?, Acta Anaesthesiol Belg, vol.64, issue.2, pp.41-48, 2013.

G. Cammu, V. Smet, D. Jongh, K. Vandeput, and D. , A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery, Anaesth Intensive Care. nov, vol.40, issue.6, pp.999-1006, 2012.

G. Geldner, M. Niskanen, P. Laurila, V. Mizikov, M. Hübler et al., A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery*, Anaesthesia, vol.101, issue.Suppl 1, pp.991-999, 2012.
DOI : 10.1213/01.ANE.0000180992.76743.C9

C. Ozgün, T. Cakan, B. Baltac?, and H. Ba?ar, Comparison of reversal and adverse effects of sugammadex and combination of -Anticholinergic-Anticholinesterase agents in pediatric patients, J Res Med Sci Off J Isfahan Univ Med Sci. août, vol.19, issue.8, pp.762-770, 2014.

M. Adamus, L. Hrabalek, T. Wanek, T. Gabrhelik, and J. Zapletalova, Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery, Journal of Anesthesia, vol.98, issue.26 Suppl, pp.716-736, 2011.
DOI : 10.1097/00000542-200305000-00004

M. Carron, E. Parotto, and C. Ori, Prolonged neuromuscular block associated to nonalcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex, Minerva Anestesiol. janv, vol.78, issue.1, pp.112-115, 2012.

T. Gaszynski, T. Szewczyk, and W. Gaszynski, Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia, British Journal of Anaesthesia, vol.108, issue.2, pp.236-245, 2012.
DOI : 10.1093/bja/aer330

G. Rocca, . Della, L. Pompei, D. Pagan, C. Paganis et al., Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study, Acta Anaesthesiologica Scandinavica, vol.111, issue.9, pp.1138-1183, 2013.
DOI : 10.1097/ALN.0b013e3182342840

X. Wu, H. Oerding, J. Liu, B. Vanacker, S. Yao et al., Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects, BMC Anesthesiology, vol.5, issue.Suppl 1, p.53, 2014.
DOI : 10.1097/00000539-200012000-00042

F. Paton, M. Paulden, D. Chambers, M. Heirs, S. Duffy et al., Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation ??? ???The research material on which this article is based is protected by Crown Copyright., British Journal of Anaesthesia, vol.105, issue.5, pp.558-67, 2010.
DOI : 10.1093/bja/aeq269

F. Pühringer, M. Gordon, I. Demeyer, H. Sparr, J. Ingimarsson et al., Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose???response relationship, British Journal of Anaesthesia, vol.105, issue.5
DOI : 10.1093/bja/aeq226

O. Sacan, P. White, B. Tufanogullari, and K. Klein, Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine???Glycopyrrolate and Edrophonium???Atropine, Anesthesia & Analgesia, vol.104, issue.3, pp.569-74, 2007.
DOI : 10.1213/01.ane.0000248224.42707.48

T. Kara, O. Ozbagriacik, H. Turk, C. Isil, O. Gokuc et al., Sugammadex versus neostigmine in pediatric patients: a prospective randomized study, Brazilian Journal of Anesthesiology (English Edition), vol.64, issue.6, pp.400-405, 2014.
DOI : 10.1016/j.bjane.2014.03.001

T. Woo, K. Kim, Y. Shim, M. Kim, S. Yoon et al., Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients, Korean Journal of Anesthesiology, vol.65, issue.6, pp.501-508, 2013.
DOI : 10.4097/kjae.2013.65.6.501

H. Illman, P. Laurila, H. Antila, O. Meretoja, S. Alahuhta et al., The Duration of Residual Neuromuscular Block After Administration of Neostigmine or Sugammadex at Two Visible Twitches During Train-of-Four Monitoring, Anesthesia & Analgesia, vol.112, issue.1, pp.63-71, 2011.
DOI : 10.1213/ANE.0b013e3181fdf889

A. Rudzka-nowak and M. Piechota, Anaesthetic management of a patient with myasthenia gravis for abdominal surgery using sugammadex, Archives of Medical Science, vol.2, issue.2, pp.361-365, 2011.
DOI : 10.5114/aoms.2011.22094

H. De-boer, J. Van-egmond, J. Driessen, and L. Booij, A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex, Revista Espa??ola de Anestesiolog??a y Reanimaci??n, vol.57, issue.3, pp.181-185, 2010.
DOI : 10.1016/S0034-9356(10)70194-8

A. Takeda, M. Kawamura, I. Hamaya, H. Kitamura, R. Muto et al., Case of anesthesia for thoracoscopic thymectomy in a pediatric patient with myasthenia gravis: reversal of rocuronium-induced neuromuscular blockade with sugammadex, Masui. août, vol.61, issue.8, pp.855-863, 2012.

N. Komasawa, H. Noma, T. Sugi, N. Sukenaga, and H. Kakiuchi, Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy, Masui. avr, vol.60, issue.4, pp.476-485, 2011.

J. Jakubiak, T. Gaszy?ski, and W. Gaszy?ski, Neuromuscular block reversal with sugammadex in a morbidly obese patient with myasthenia gravis, Anaesthesiol Intensive Ther. mars, vol.44, issue.1, pp.28-30, 2012.

H. Argiriadou, K. Anastasiadis, E. Thomaidou, and D. Vasilakos, Reversal of neuromuscular blockade with sugammadex in an obese myasthenic patient undergoing thymectomy, Journal of Anesthesia, vol.65, issue.2, pp.316-323, 2011.
DOI : 10.1111/j.1365-2044.2009.06236.x

H. De-boer, M. Shields, and L. Booij, Reversal of neuromuscular blockade with sugammadex in patients with myasthenia gravis, European Journal of Anaesthesiology, vol.31, issue.12, pp.715-736, 2014.
DOI : 10.1097/EJA.0000000000000153

Z. Sungur-ulke, A. Yavru, E. Camci, B. Ozkan, A. Toker et al., Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy, Acta Anaesthesiologica Scandinavica, vol.51, issue.6, pp.745-753, 2013.
DOI : 10.1111/j.1399-6576.2007.01352.x

A. Petrun, D. Mekis, and M. Kamenik, Successful use of rocuronium and sugammadex in a patient with myasthenia, European Journal of Anaesthesiology, vol.27, issue.10, pp.917-925, 2010.
DOI : 10.1097/EJA.0b013e3283392593

M. Naharro, J. , G. Pardo, M. , O. Sánchez et al., Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis, Rev Esp Anestesiol Reanim. déc, vol.58, issue.10, pp.624-629, 2011.

C. Belval, A. Tramoni, G. Vedrinne, J. Olagne, E. Vigneron et al., [The use of sugammadex in a patient with myasthenia gravis]. Ann Fr Anesthèsie Rèanimation, juin, vol.31, issue.6, pp.569-70, 2012.

C. Unterbuchner, H. Fink, and M. Blobner, The use of sugammadex in a patient with myasthenia gravis, Anaesthesia, vol.49, issue.3, pp.302-307, 2010.
DOI : 10.1097/00007611-199106000-00007

V. Garcia, P. Diemunsch, and S. Boet, Use of rocuronium and sugammadex for caesarean delivery in a patient with myasthenia gravis, International Journal of Obstetric Anesthesia, vol.21, issue.3, pp.286-293, 2012.
DOI : 10.1016/j.ijoa.2012.02.006

M. Khan and A. Banerjee, Anaesthesia and orphan disease, European Journal of Anaesthesiology, vol.29, issue.12, pp.593-598, 2012.
DOI : 10.1097/EJA.0b013e328356472a

T. Suzuki, K. Nameki, H. Shimizu, Y. Shimizu, R. Nakamura et al., Efficacy of rocuronium and sugammadex in a patient with dermatomyositis, British Journal of Anaesthesia, vol.108, issue.4, p.703, 2012.
DOI : 10.1093/bja/aes087

L. Pellegrini, M. Mercier, A. Cornese, V. Blasco, and J. Albanèse, Induction en s??quence rapide chez un patient porteur d???une dystrophie myotonique de Steinert??: int??r??t de l???association d???une forte dose de rocuronium et de sugammadex, Annales Fran??aises d'Anesth??sie et de R??animation, vol.31, issue.2, pp.155-162, 2012.
DOI : 10.1016/j.annfar.2011.10.031

G. Weekes, N. Hayes, and M. Bowen, Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis, International Journal of Obstetric Anesthesia, vol.19, issue.3, pp.333-339, 2010.
DOI : 10.1016/j.ijoa.2010.03.009

H. De-boer, J. Van-esmond, L. Booij, and J. Driessen, Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy, Pediatric Anesthesia, vol.24, issue.12, pp.1226-1234, 2009.
DOI : 10.1111/j.1460-9592.2008.02417.x

A. Kashiwai, T. Suzuki, and S. Ogawa, Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy, Case Reports in Anesthesiology, vol.102, issue.1, p.107952, 2012.
DOI : 10.1007/s00540-005-0348-7

M. Yamada and T. Kimura, Successful use of sugammadex in a muscular dystrophy patient, Masui. oct, vol.60, issue.10, pp.1205-1211, 2011.

W. Shousha, A. Sanfilippo, M. Sabba, A. Pinchera, and P. , Sugammadex and reversal of neuromuscular block in adult patient with duchenne muscular dystrophy, Case Rep Anesthesiol, vol.2014, p.680568, 2014.

G. Cañellas, J. Errando, C. , O. Arana, A. Falcó et al., Sugammadex, efficacious in reversing a neuromuscular block in a woman with Becker muscular dystrophy, Rev Esp Anestesiol Reanim. déc, vol.58, issue.10, pp.614-621, 2011.

P. Stourac, I. Krikava, J. Seidlova, E. Strazevska, M. Huser et al., Sugammadex in a parturient with myotonic dystrophy, British Journal of Anaesthesia, vol.110, issue.4, pp.657-665, 2013.
DOI : 10.1093/bja/aet037

P. Stewart, S. Phillips, D. Boer, and H. , Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy, Revista Espa??ola de Anestesiolog??a y Reanimaci??n, vol.60, issue.4, pp.226-235, 2013.
DOI : 10.1016/j.redar.2012.07.007

R. Takeuchi, H. Hoshijima, K. Doi, and H. Nagasaka, The use of sugammadex in a patient with Kennedy's disease under general anesthesia, Saudi J Anaesth. juill, vol.8, issue.3, pp.418-438, 2014.

T. Shimauchi, K. Yamaura, S. Sugibe, and S. Hoka, Usefulness of sugammadex in a patient with Becker muscular dystrophy and dilated cardiomyopathy, Acta Anaesthesiologica Taiwanica, vol.52, issue.3, pp.146-154, 2014.
DOI : 10.1016/j.aat.2014.02.005

E. Kelsaka, D. Karakaya, and E. Zengin, Use of Sugammadex in a Patient with Amyotrophic Lateral Sclerosis, Medical Principles and Practice, vol.22, issue.3, pp.304-310, 2013.
DOI : 10.1159/000343168

M. Wachi, K. Uehara, W. Fujinaka, M. Takatori, and K. Tada, Use of sugammadex in a patient with amyotrophic lateral sclerosis], Masui. déc, vol.60, issue.12, pp.1408-1418, 2011.

K. Mogi, S. Shiba, Y. Hirabayashi, and N. Seo, Use of sugammadex in a patient with limb girdle muscular dystrophy, Masui. juin, vol.60, issue.6, pp.710-712, 2011.

C. Czarnetzki, E. Tassonyi, C. Lysakowski, N. Elia, and M. Tramèr, Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium-induced Neuromuscular Block in Patients Pretreated with Intravenous Magnesium, Anesthesiology, vol.121, issue.1, pp.59-67, 2014.
DOI : 10.1097/ALN.0000000000000204

Y. Sakurai, M. Uchida, J. Aiba, F. Mimura, M. Yamaguchi et al., Reversal of rocuronium-induced neuromuscular blockade with sugammadex in patients for cesarean delivery treated with magnesium sulfate, Masui. mars, vol.63, issue.3, pp.315-324, 2014.

M. Carron, Sugammadex after magnesium sulphate administration in a morbidly obese patient undergoing general anaesthesia, British Journal of Anaesthesia, vol.112, issue.5, pp.949-50, 2014.
DOI : 10.1093/bja/aeu129

B. Grandjean, P. Guerci, . Vial-null, J. Raft, T. Fuchs-buder et al., Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate. Ann Fr Anesthésie Réanimation, pp.378-387, 2013.

G. Veiga-ruiz, N. Domínguez, J. Orozco, M. Janda, R. Hofmockel et al., Eficacia de la reversi??n con sugammadex del bloqueo neuromuscular inducido por rocuronio en cirug??a de larga duraci??n. Comparaci??n del efecto de la anestesia inhalatoria frente a intravenosa, Revista Espa??ola de Anestesiolog??a y Reanimaci??n, vol.56, issue.6, pp.349-54, 2009.
DOI : 10.1016/S0034-9356(09)70407-4

C. Rex, S. Wagner, C. Spies, J. Scholz, H. Rietbergen et al., Reversal of Neuromuscular Blockade by Sugammadex after Continuous Infusion of Rocuronium in Patients Randomized to Sevoflurane or Propofol Maintenance Anesthesia, Anesthesiology, vol.111, issue.1, pp.30-35, 2009.
DOI : 10.1097/ALN.0b013e3181a51cb0

B. Vanacker, K. Vermeyen, M. Struys, H. Rietbergen, E. Vandermeersch et al., Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane, Anesthesia & Analgesia, vol.104, issue.3, pp.563-571, 2007.
DOI : 10.1213/01.ane.0000231829.29177.8e

T. Murata, T. Kubodera, M. Ohbayashi, K. Murase, Y. Adachi et al., Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia, Canadian Journal of Anesthesia/Journal canadien d'anesth??sie, vol.61, issue.5, pp.508-517, 2013.
DOI : 10.1007/s12630-011-9554-y

H. Lemmens, M. El-orbany, J. Berry, J. Morte, and G. Martin, Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine, BMC Anesthesiology, vol.104, issue.1, p.15, 2010.
DOI : 10.1213/01.ane.0000244594.63318.fc

S. Groudine, R. Soto, C. Lien, D. Drover, and K. Roberts, A Randomized, Dose-Finding, Phase II Study of the Selective Relaxant Binding Drug, Sugammadex, Capable of Safely Reversing Profound Rocuronium-Induced Neuromuscular Block, Anesthesia & Analgesia, vol.104, issue.3, pp.555-62, 2007.
DOI : 10.1213/01.ane.0000260135.46070.c3

H. Sparr, K. Vermeyen, A. Beaufort, H. Rietbergen, J. Proost et al., Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study, Anesthesiology, vol.106, issue.5, pp.935-978, 2007.
DOI : 10.1097/01.anes.0000265152.78943.74

D. Mcdonagh, P. Benedict, A. Kovac, D. Drover, N. Brister et al., Efficacy, Safety, and Pharmacokinetics of Sugammadex for the Reversal of Rocuronium-induced Neuromuscular Blockade in Elderly Patients, Anesthesiology, vol.114, issue.2, pp.318-347, 2011.
DOI : 10.1097/ALN.0b013e3182065c36

M. Shields, M. Giovannelli, R. Mirakhur, I. Moppett, J. Adams et al., Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block, British Journal of Anaesthesia, vol.96, issue.1, pp.36-43, 2006.
DOI : 10.1093/bja/aei314

F. Pühringer, C. Rex, A. Sielenkämper, C. C. Larsen, P. Prins et al., Reversal of Profound, High-dose Rocuronium???induced Neuromuscular Blockade by Sugammadex at Two Different Time Points, Anesthesiology, vol.109, issue.2, pp.188-97, 2008.
DOI : 10.1097/ALN.0b013e31817f5bc7

C. Lee, J. Jahr, K. Candiotti, B. Warriner, M. Zornow et al., Reversal of Profound Neuromuscular Block by Sugammadex Administered Three Minutes after Rocuronium, Anesthesiology, vol.110, issue.5, pp.1020-1025, 2009.
DOI : 10.1097/ALN.0b013e31819dabb0

R. Jones, J. Caldwell, S. Brull, and R. Soto, Reversal of Profound Rocuronium-induced Blockade with Sugammadex, Anesthesiology, vol.109, issue.5, pp.816-840, 2008.
DOI : 10.1097/ALN.0b013e31818a3fee

H. De-boer, J. Driessen, M. Marcus, H. Kerkkamp, M. Heeringa et al., Reversal of Rocuronium-induced (1.2 mg/kg) Profound Neuromuscular Block by Sugammadex, Anesthesiology, vol.107, issue.2, pp.239-283, 2007.
DOI : 10.1097/01.anes.0000270722.95764.37

M. Blobner, L. Eriksson, J. Scholz, J. Motsch, G. Rocca et al., Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial, European Journal of Anaesthesiology, vol.27, issue.10, pp.874-81, 2010.
DOI : 10.1097/EJA.0b013e32833d56b7

B. Plaud, O. Meretoja, R. Hofmockel, J. Raft, P. Stoddart et al., Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients, Anesthesiology, vol.PAP, issue.2, pp.284-94, 2009.
DOI : 10.1097/ALN.0b013e318194caaa

I. Sorgenfrei, K. Norrild, P. Larsen, J. Stensballe, D. Ostergaard et al., Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex, Anesthesiology, vol.104, issue.4, pp.667-74, 2006.
DOI : 10.1097/00000542-200604000-00009

E. Flockton, P. Mastronardi, J. Hunter, C. Gomar, R. Mirakhur et al., Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine, British Journal of Anaesthesia, vol.100, issue.5, pp.622-652, 2008.
DOI : 10.1093/bja/aen037

V. Dahl, P. Pendeville, M. Hollmann, T. Heier, E. Abels et al., Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery, European Journal of Anaesthesiology, vol.26, issue.10, pp.874-84, 2009.
DOI : 10.1097/EJA.0b013e32832c605b

S. Schaller, H. Fink, K. Ulm, and M. Blobner, Sugammadex and Neostigmine Dose-finding Study for Reversal of Shallow Residual Neuromuscular Block, Anesthesiology, vol.113, issue.5, pp.1054-60, 2010.
DOI : 10.1097/ALN.0b013e3181f4182a

R. Amao, M. Zornow, R. Cowan, D. Cheng, J. Morte et al., Use of sugammadex in patients with a history of pulmonary disease, Journal of Clinical Anesthesia, vol.24, issue.4, pp.289-97, 2012.
DOI : 10.1016/j.jclinane.2011.09.006

F. Yoshida, T. Suzuki, A. Kashiwai, T. Furuya, J. Konishi et al., Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex, Acta Anaesthesiologica Scandinavica, vol.100, issue.1, pp.83-90, 2012.
DOI : 10.1093/bja/aem409

L. Pompei, G. Rocca, and . Della, Rocuronium and sugammadex administration in patients undergoing orthtopic liver transplantation, LWW. juin, vol.29, p.142, 2012.

S. Llauradó, A. Sabaté, E. Ferreres, I. Camprubí, and A. Cabrera, Sugammadex Ideal Body Weight Dose Adjusted by Level of Neuromuscular Blockade in Laparoscopic Bariatric Surgery, Anesthesiology, vol.117, issue.1, pp.93-101, 2012.
DOI : 10.1097/ALN.0b013e3182580409

M. Shibusawa, Y. Ejima, R. Nishino, H. Toyama, and S. Kurosawa, Use of sugammadex in patients undergoing caesarean section using general anesthesia with rocuronium, Masui. août, vol.61, issue.8, pp.805-814, 2012.

C. Batistaki, P. Matsota, K. Kalimeris, E. Brountzos, and G. Kostopanagiotou, Sugammadex antagonising rocuronium in three patients with liver dysfunction undergoing transjugular intrahepatic portosystemic shunt, Anaesth Intensive Care. mai, vol.40, issue.3, pp.556-563, 2012.

P. White, B. Tufanogullari, O. Sacan, E. Pavlin, O. Viegas et al., The Effect of Residual Neuromuscular Blockade on the Speed of Reversal with Sugammadex, Anesthesia & Analgesia, vol.108, issue.3, pp.846-51, 2009.
DOI : 10.1213/ane.0b013e31818a9932

A. Sugawara, T. Sasakawa, N. Hasegawa, O. Takahata, and H. Iwasaki, Administration of sugammadex to a patient with myasthenia gravis with fade of the train-of-four ratio, Masui. sept, vol.60, issue.9, pp.1082-1087, 2011.

A. Bellod, X. March, C. Hernandez, and A. Villalonga, Delayed recurarisation after sugammadex reversal, European Journal of Anaesthesiology, vol.31, issue.12, pp.710-712, 2014.
DOI : 10.1097/EJA.0000000000000132

URL : http://pdfs.journals.lww.com/ejanaesthesiology/2014/12000/Delayed_recurarisation_after_sugammadex_reversal.11.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1506615565278;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGZnEagBFgfcfP0kYnmKqyo4jnB5MymexME8oawjJRHf/KYjeJpspUJZc7Dkh4PcQ;hash|NodVLj5GTTERHJIEt7zfhQ==

G. Kiss, A. Lacour, and A. Hollander, Fade of train-of-four ratio despite administration of more than 12 mg kg ???1 sugammadex in a myasthenia gravis patient receiving rocuronium, British Journal of Anaesthesia, vol.110, issue.5, pp.854-859, 2013.
DOI : 10.1093/bja/aet098

J. Ortiz-gómez, F. Palacio-abizanda, and I. Fornet-ruiz, Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade, European Journal of Anaesthesiology, vol.31, issue.12, pp.708-717, 2014.
DOI : 10.1097/EJA.0000000000000082

K. Kayashima, R. Sozen, and D. Okura, Insufficient sugammadex effect in an obese pregnant woman undergoing cesarean section under general anesthesia, Masui. févr, vol.63, issue.2, pp.188-90, 2014.

C. Unterbuchner, R. Ziegleder, B. Graf, and T. Metterlein, Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex, Acta Anaesthesiologica Scandinavica, vol.120, issue.4, pp.536-576, 2015.
DOI : 10.1097/ALN.0000000000000043

L. Corre, F. Nejmeddine, S. Fatahine, C. Tayar, C. et al., Recurarisation apr??s d??curarisation avec le sugammadex chez une patiente ob??se, Canadian Journal of Anesthesia/Journal canadien d'anesth??sie, vol.111, issue.10, pp.944-951, 2011.
DOI : 10.1213/ANE.0b013e3181e1d94c

M. Briere, C. Boisson, P. Cuvillon, B. Debaene, and J. Ripart, Sugammadex and renal failure: a case report]. Ann Fr Anesthèsie Rèanimation, oct, vol.30, issue.10, pp.743-748, 2011.

B. Debaene and C. Meistelman, Indications et utilisation clinique du sugammadex. Ann Fr Anesth Réanimation, sept Supplement, vol.28, issue.2, pp.57-63, 2009.

D. Schmartz, P. Guerci, and T. Fuchs-buder, Sugammadex Dosing in Bariatric Patients, Anesthesiology, vol.118, issue.3, p.754, 2013.
DOI : 10.1097/ALN.0b013e31827bd335

T. Fuchs-buder, C. Claudius, L. Skovgaard, L. Eriksson, R. Mirakhur et al., Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision, Acta Anaesthesiologica Scandinavica, vol.1, issue.7, pp.789-808, 2007.
DOI : 10.1002/9780470773666

J. Proost, L. Eriksson, R. Mirakhur, G. Roest, and J. Wierda, Urinary, biliary and faecal excretion of rocuronium in humans, British Journal of Anaesthesia, vol.85, issue.5, pp.717-740, 2000.
DOI : 10.1093/bja/85.5.717

R. Cooper, V. Maddineni, R. Mirakhur, J. Wierda, M. Brady et al., TIME COURSE OF NEUROMUSCULAR EFFECTS AND PHARMACOKINETICS OF ROCURONIUM BROMIDE (ORG 9426) DURING ISOFLURANE ANAESTHESIA IN PATIENTS WITH AND WITHOUT RENAL FAILURE, British Journal of Anaesthesia, vol.71, issue.2, pp.222-228, 1993.
DOI : 10.1093/bja/71.2.222

D. Eleveld, K. Kuizenga, J. Proost, and J. Wierda, A Temporary Decrease in Twitch Response During Reversal of Rocuronium-Induced Muscle Relaxation with a Small Dose of Sugammadex, Anesthesia & Analgesia, vol.104, issue.3, pp.582-586, 2007.
DOI : 10.1213/01.ane.0000250617.79166.7f

L. Staals, M. Snoeck, J. Driessen, H. Van-hamersvelt, E. Flockton et al., Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study ???, British Journal of Anaesthesia, vol.104, issue.1, pp.31-40, 2010.
DOI : 10.1093/bja/aep340

M. Binhas, A. Bouyoucef, M. Paul, G. Honneur, and B. Plaud, Utilisation du sugammadex chez l???insuffisant r??nal chronique terminal, dialys??, Annales Fran??aises d'Anesth??sie et de R??animation, vol.31, issue.12, pp.972-975, 2012.
DOI : 10.1016/j.annfar.2012.09.006

I. Panhuizen, S. Gold, C. Buerkle, M. Snoeck, N. Harper et al., Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg ???1 for reversal of deep neuromuscular blockade in patients with severe renal impairment, British Journal of Anaesthesia, vol.114, issue.5, pp.777-84, 2015.
DOI : 10.1093/bja/aet586

. Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function, Br J Anaesth. oct, vol.101, issue.4, pp.492-499, 2008.

T. Fuchs-buder and E. Tassonyi, Magnesium sulphate enhances residual neuromuscular block induced by vecuronium, British Journal of Anaesthesia, vol.76, issue.4, pp.565-571, 1996.
DOI : 10.1093/bja/76.4.565

URL : http://doc.rero.ch/record/290740/files/8652332.pdf

G. Hans, B. Bosenge, V. Bonhomme, J. Brichant, I. Venneman et al., Intravenous magnesium re-establishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium, European Journal of Anaesthesiology, vol.29, issue.2, pp.95-104, 2012.
DOI : 10.1097/EJA.0b013e32834e13a6

J. Mulier, P. Dubois, H. De-boer, and L. Debaerdemaeker, Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade, European Journal of Anaesthesiology, vol.32, issue.10, pp.743-747, 2015.
DOI : 10.1097/EJA.0000000000000301